The $375 central target is the rounded arithmetic mean of 14 recent analyst price targets I collected and verified from identifiable firms. These include KBW at $425, Piper Sandler at $405, RBC Capital at $400, Goldman Sachs at $400, Wells Fargo at $415, BofA at $369, Truist at $375, BMO Capital at $380, Morgan Stanley at $380, J.P. Morgan at $360, Barclays at $342, TD Cowen at $335, Citi at $335, and Evercore ISI at $330.
The spread is unusually wide — roughly $330 to $425 — which matters more than the single midpoint. Bulls argue American Express's affluent customer base and premium economics justify a richer multiple, while skeptics point to softer spending trends and an elevated valuation. The ratings mix leans constructive but cautious: recent data show roughly 14 to 16 Buy-equivalent ratings against about 15 Hold ratings, with essentially no Sell ratings, indicating a "Moderate Buy" or "Hold" leaning rather than an emphatic consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent revisions have tilted slightly negative. BofA cut its target to $369 from $382, J.P. Morgan lowered to $360 from $400, Morgan Stanley trimmed to $380 from $382, and Evercore ISI reduced to $320 from $370 before a small rebound to $330. Offsetting these, KBW reaffirmed $425 and BMO Capital initiated coverage at $380 in October 2026. This mixed picture means the average should be read as a statistical midpoint, not a guarantee.
American Express shares closed near $321 in early November 2026, within a 52-week range of roughly $291 to $387. Reaching $375 implies about a 17% upside, which I would characterize as substantial rather than modest or extreme.
For the company's September 2026 quarter, American Express reported revenue of about $21.98 billion and net income of roughly $3.71 billion, up from $20.56 billion and $2.9 billion a year earlier. Management's 2026 guidance calls for revenue growth of roughly 9% to 10% and EPS (earnings per share) of $17.30 to $17.90, alongside a planned 16% dividend increase. At a P/E (price-to-earnings) ratio near 18 times trailing earnings, the stock trades at a premium to many banks but a discount to its own five-year median — a key variable in whether the market re-rates shares toward the target.
Several factors could underpin an advance toward $375. American Express's closed-loop network — where it acts as both issuer and merchant acquirer — generates strong economics, with returns on equity in the mid-30% range. Its affluent, high-credit-quality customer base has historically shown resilience through cycles. Continued loan and card-fee growth, disciplined expense management, and a robust buyback program all support EPS growth that could justify a higher valuation.
Broader sector momentum and stable-to-improving consumer credit trends would help. If spending among high-income households and Millennial/Gen Z cohorts holds up and travel-and-entertainment demand recovers, analysts may begin raising estimates and targets again, drawing the stock toward the mean target.
The principal obstacles are macro and valuation-related. A slowing consumer, rising delinquency rates, or a pullback in travel and business spending would pressure revenue and credit costs. The recent pattern of target cuts from BofA, J.P. Morgan, Morgan Stanley, and Evercore ISI suggests some analysts already see downside risk to estimates or worry the premium valuation leaves limited margin for error.
Competition from other card issuers and fintech players, higher customer-acquisition costs, and any compression in the company's above-market multiple could all keep shares below $375 even if earnings meet expectations. If the market continues to rotate away from consumer-finance names, a re-rating lower is possible.
The stock's 52-week high near $387 stands as the nearest major resistance zone, with the psychological $400 level just beyond it. A durable advance toward $375 would first need to clear the area between roughly $350 and $365, where the stock has spent meaningful time. On the downside, support is visible near the recent $307–$313 area, with the 52-week low near $291 providing a deeper floor. The long-term structure remains intact but choppy, reflecting the divided analyst views. From what I see, monitoring these levels closely helps frame realistic expectations.
Analyst price targets generally reflect a research horizon of about 12 months, though individual firms apply different timelines and assumptions. The next earnings release is a key checkpoint, along with any updates to 2026 revenue and EPS guidance. Investors should watch consumer-credit data, delinquency and write-off trends, travel-and-entertainment spending, and further analyst revisions. Macroeconomic indicators, Federal Reserve rate decisions, and sector rotation in and out of consumer-finance stocks will also influence the path. None of these observations constitutes a forecast.
In my own work, I often turn to Tickeron’s AI Daily Buy/Sell Signals to get an additional data-driven perspective on stocks like American Express. These signals apply artificial intelligence to scan thousands of equities and ETFs, producing Buy, Sell, or Hold indications based on technical behavior and market shifts. Adding this layer to traditional analysis can help investors stay objective when evaluating whether a name like AXP is building momentum toward a higher price target.
Whether American Express can reach $375 hinges on earnings durability and valuation. The $375 central target — a rounded mean of 14 analyst targets spanning $330 to $425 — implies a substantial 17% move from the current price near $321. Support could come from resilient affluent spending, premium economics, and continued buybacks, while risks include a consumer slowdown, soft travel demand, and a rich valuation that leaves little room for disappointment. The wide analyst range and recent mix of cuts and reaffirmations signal genuine uncertainty. Investors should watch earnings, credit quality, and analyst revisions rather than treat any single price target as a certainty.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AXP moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 36 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 72%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on AXP as a result. In 48 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for AXP just turned positive on October 06, 2026. Looking at past instances where AXP's MACD turned positive, the stock continued to rise in 30 of 44 cases over the following month. The odds of a continued upward trend are 68%.
The 10-day moving average for AXP crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +3.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXP advanced for three days, in 204 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 174 of 282 cases where AXP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The 10-day RSI Indicator for AXP moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 26 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 64 cases where AXP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
AXP broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 4 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating steady price growth. AXP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.323) is normal, around the industry mean (3.902). P/E Ratio (19.442) is within average values for comparable stocks, (6.401). Projected Growth (PEG Ratio) (1.232) is also within normal values, averaging (3.918). Dividend Yield (0.012) settles around the average of (0.189) among similar stocks. P/S Ratio (2.824) is also within normal values, averaging (5.901).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a financial conglomerate
Industry SavingsBanks